Reference List
- Storms W. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Expert Opin Pharmacother 2007; 8:2173–2187.
- de Benedictis FM, Vaccher S, de Benedictis D. Montelukast sodium for exercise-induced asthma. Drugs Today (Barc) 2008; 44:845–855.
- Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis: An evidence-based review. Drugs 2007; 67:887–901.
- Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: A systematic review. Thorax 2008; 63:453–462.
- Reiss TF, Sorkness CA, Stricker W, Botto A, Busse WW, Kundu S, Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax 1997; 52:45–48.
- Reiss TF, Altman LC, Chervinsky P, Bewtra A, Stricker WE, Noonan GP, Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma. J Allergy Clin Immunol 1996; 98:528–534.
- Altman LC, Munk Z, Seltzer J, Noonan N, Shingo S, Zhang J, A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group. J Allergy Clin Immunol 1998; 102:50–56.
- Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W, Comparison of the effects of intravenous and oral montelukast on airway function: A double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 2000; 55:260–265.
- Standardization of Spirometry. 1994 Update. American thoracic society. Am J Respir Crit Care Med 1995; 152:1107–1136.
- PROAIR® HFA (albuterol sulfate) inhalation aerosol package insert. Teva Specialty Pharmaceuticals LLC, Horsham, PA, 2008.
- Noonan MJ, Chervinsky P, Brandon M, Zhang J, Kundu S, McBurney J, Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group. Eur Respir J 1998; 11:1232–1239.